Opinion statement
Many patients who present to neurology settings with somatic complaints have underlying fear of illness, anxiety, or depression. Hypochondriasis, which is one of the somatoform disorders, contributes to high use of services and frustration on the part of clinicians, because diagnostic and treatment interventions often fail. The challenges for clinicians include how to distinguish true somatic symptoms from those associated with fear or other psychiatric symptoms. Our goal is to provide the clinician with an integrated approach for the triage, assessment (history, screening tools, examination, and diagnostic tests), and treatment of these challenging patients. Recommendations are made regarding psychiatric consultation and comanagement between fields for complex patients.
Similar content being viewed by others
References and Recommended Reading
Van den Heuvel OA, Veltman DJ, Groenewegen HJ, et al.: Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder and hypochondriasis. Arch Gen Psychiatry 2005, 62:922–933. Explores neuroanatomical underpinnings of hypochondriasis.
Diagnostic and Statistical Manual of Mental Disorders, edn 4. Training Revision. Washington, DC: American Psychiatric Association; 2002.
Reuber M, Mitchell AJ, Howlett SJ, et al.: Functional symptoms in neurology: questions and answers. J Neurol Neurosurg Psychiatry 2005, 76:307–314. Overview of somatoform disorders for neurology.
Fink P, Hansen MS, Søndergaard L: Somatoform disorders among first-time referrals to a neurology service. Psychosomatics 2005, 46:540–548. Information on hypochondriasis specific to neurology.
Magarinos M, Zafar U, Nissenson K, et al.: Epidemiology and treatment of hypochondriasis. CNS Drugs 2002, 16:9–22.
Rode S, Slkovskis, Dowd H, et al.: Health anxiety levels in chronic pain clinic attenders. J Psychosom Res 2006, 60:155–161.
Barsky AJ, Ettner SL, Horsky J, et al.: Resource utilization of patients with hypochondriacal health anxiety and somatization. Med Care 2001, 39:705–715.
Barsky AJ, Wyshak G, Klerman GL: Psychiatric comorbidity in DSM-III-R hypochondriasis. Arch Gen Psychiatry 1992, 49:101–108.
Hollander E, Neville D, Frenkel M, et al.: Body dysmorphic disorder: diagnostic issues and related disorders. Psychosomatics 1992, 33:156–165.
Toft T, Fink P, Oernboel E, et al.: Mental disorders in primary care: prevalence and co-morbidity among disorders and results from the functional illness in primary care (FIP) study. Psychol Med 2005, 35:1175–1184. Contrast of neurology with primary care.
Noyes R, Watson DB, Carney CP, et al.: Risk factors for hypochondriacal concerns in a sample of military veterans. J Psychosom Res 2004, 57:529–539.
Applegate KL, Keefe FJ, Siegler IC, et al.: Does personality at college entry predict number of reported pain conditions at mid-life? A longitudinal study. J Pain 2005, 6:92–97.
Melley AH, Oltmanns TF, Turkheimer E: The Schedule for Nonadaptive and Adaptive Personality (SNAP): temporal stability and predictive validity of the diagnostic scales. Assessment 2002, 9:181–187.
Noyes R Jr, Watson DB, Letuchy EM, et al.: Relationship between hypochondriacal concerns and personality dimensions and traits in a military population. J Nerv Ment Dis 2005, 193:110–118.
Walker J, Vincent N, Furer P: Treatment preference in hypochondriasis. J Behav Ther Exp Psychiatry 1999, 30:251–258.
Kroenke K, Swindle R: Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000, 69:205–215.
Visser S, Bouman TK: The treatment of hypochondriasis: exposure plus response prevention vs cognitive therapy. Behav Res Ther 2001, 39:423–442. Review of psychosocial treatments.
Looper KJ, Kirmayer LJ: Behavioral medicine approaches to somatoform disorders. Consult Clin Psychol 2002, 70:810–827.
Kellner R: Psychotherapeutic strategies in hypochondriasis: a clinical study. Am J Psychother 1982, 36:146–157. Resource on all treatments for hypochondriasis.
House A: Hypochondriasis and related disorders. Assessment and management of patients referred for a psychiatric opinion. Gen Hosp Psychiatry 1989, 11:156–165.
Barsky AJ: Hypochondriasis. Medical management and psychiatric treatment. Psychosomatics 1996, 37:48–56.
Bouman TK: A community-based psychoeducational group approach to hypochondriasis. Psychother Psychosom 2002, 71:326–332.
Lidbeck J: Group therapy for somatization disorders in primary care: maintenance of treatment goals of short cognitive-behavioural treatment one-and-a-halfyear follow-up. Acta Psychiatr Scand 2003, 107:449–456.
Ladee GA: Hypochondriacal Syndromes. New York: Elsevier; 1966.
Fink P, Ornbol E, Toft T, et al.: A new, empirically established hypochondriasis diagnosis. Am J Psychiatry 2004, 161:1680–1691.
Hirschfeld RMA, Mallinckrofodt C, Lee TC, et al.: Time course of depression-symptom improvement during treatment with duloxetine. Depr Anxiety 2005, 21:170–177.
Kellner R, Abbott P, Pathak D, et al.: Hypochondriacal beliefs and attitudes in family practice and psychiatric patients. Int J Psychiatry Med 1983–84, 13:127–139.
Speckens AEM, Spinhoven P, Sloekers PPA, et al.: A validation study of the Whitely Index, the Illness Attitude Scale, and the Somatosensory Amplification Scale in general medical and general practice patients. J Psychosom Res 1996, 40:95–104.
Janca A, Isaac M, Costae Silva JA: World Health Organization International Study of Somatoform Disorders: background and rationale. Eur J Psychiatry 1995, 9:100–110.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hilty, D.M., Bourgeois, J.A. & Chang, C.H. Diagnostic and treatment interventions for hypochondriasis in the neurology setting. Curr Treat Options Neurol 8, 401–409 (2006). https://doi.org/10.1007/s11940-006-0029-3
Issue Date:
DOI: https://doi.org/10.1007/s11940-006-0029-3